(Q44014642)

28 November 2017

title

Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain (English)

1 reference

28 November 2017

0 references

0 references

0 references

Susana Mato

1

1 reference

28 November 2017

Angel Pazos

series ordinal

2

1 reference

28 November 2017

Elsa M Valdizán

series ordinal

3

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

European Journal of Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

443

1 reference

28 November 2017

issue

1-3

1 reference

28 November 2017

page(s)

43-46

1 reference

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Inhibitory effects of SR141716A on G-protein activation in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

Precoupling of Gi/G(o)-linked receptors and its allosteric regulation by monovalent cations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901575-3

10.1016/S0014-2999(02)01575-3

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference